Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675]
- PMID: 31859161
- DOI: 10.1016/j.bmcl.2019.126771
Corrigendum to 'Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors' [Bioorg. Med. Chem. Lett. 29 (2019) 126675]
Erratum for
- 
  
  Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors.Bioorg Med Chem Lett. 2019 Oct 15;29(20):126675. doi: 10.1016/j.bmcl.2019.126675. Epub 2019 Sep 7. Bioorg Med Chem Lett. 2019. PMID: 31521475
Publication types
LinkOut - more resources
- Full Text Sources
 
        